Health in Spain 1,087 indicators covering health for Spain. IndicatorLatest Year10-yr change Rank Expenditure for selected health care functions by health care financin 138,155 Million euro 2023 up 47.4% 5th Health care expenditure by provider 138,155 Million euro 2023 up 47.4% 5th Expenditure for selected health care providers by health care financin 138,155 Million euro 2023 up 47.4% 5th Expenditure for selected health care functions by health care provider 138,155 Million euro 2023 up 47.4% 5th Persons having a longstanding health problem by level of disability (a 13.8% 2025 up 25.5% 14th Self-perceived health by level of disability (activity limitation), se 93.5% 2025 down 1.8% 17th Healthy life expectancy based on self-perceived health 78.4 Year 2024 up 2.3% 5th Deaths and disappearances during migration 389 2024 up 923.7% 7th Infant mortality by age and sex 252 Number 2024 down 19.7% 9th Number of imported cases of cutaneous leishmaniasis reported 9 2023 down 55.0% 14th Number of imported cases of visceral leishmaniasis reported 5 2024 up 400.0% 7th Health impacts of air pollution 140,261 Number 2023 down 15.8% 6th Technical resources in hospital 4,875 Number 2024 up 12.0% 4th Persistence to last grade of primary 99.9% 2016 up 2.2% 2nd Primary health care expenditure (PHCE) per сapita in US$ 1,261 2023 up 38.8% 19th Revenues of health care financing schemes 138,155 Million euro 2023 up 47.4% 3rd Revenues of health care financing schemes by health care financing sch 138,155 Million euro 2023 up 47.4% 3rd Deaths related to infectious diseases 4,136 Number 2024 up 25.9% 5th Causes of death - infant mortality by country of occurrence 970 Number 2024 down 21.3% 7th Fetal, peri- and neonatal mortality rates by country of occurrence 2.6 Rate 2024 down 16.1% 29th Peri-neonatal mortality by age of mother, country of residence and occ 819 Number 2024 down 39.2% 6th Reported cases of gonorrhea 34,072 2023 up 927.8% 4th Reported cases of syphilis 10,591 2023 up 184.5% 3rd Causes of death - potential years of life lost by treatable and preven 2,270 Year 2023 down 13.5% 28th People having a long-standing illness or health problem, by sex, age a 26.2% 2025 up 23.0% 11th Treatable and preventable mortality of residents by cause and sex 77,172 Number 2023 up 4.4% 8th Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicr 2.8 2022 down 70.6% 37th Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicr 213 2022 up 102.9% 19th Causes of death - infant mortality by country of residence 843 Number 2023 down 26.7% 8th Influenza vaccination rate elderly oecd 69 2021 up 19.6% 7th Reported cases of chlamydia 36,967 2023 up 2,343.3% 6th Excess mortality by month 0.1% 2026 down 98.7% 10th Consumption of antibiotics in the community and hospital sectors - def 24.2 Per thousand inhabitants 2024 down 12.0% 5th Total use of antibacterials expressed as DDD per 1000 inhabitants per 25.39 2023 down 8.5% 10th Pattern of antibiotic consumption at national level 62.03 2023 down 2.1% 28th Hospital days of in-patients - historical data 37.57 million Number 2021 up 18.8% 7th Hospital discharges by diagnosis, in-patients, total number - historic 4.51 million Number 2021 down 4.9% 7th Hospital discharges by diagnosis, in-patients, per 100 000 inhabitants 9,519 Per hundred thousand inhabitants 2021 down 6.8% 22nd Infant mortality by mother's educational attainment level (ISCED11f) a 965 Number 2024 — 5th Imports in 1000s hectolitres 2.86 2007 down 15.3% 119th Hospital discharges by diagnosis, day cases, total number - historical 4.72 million Number 2021 up 26.3% 3rd Number of isolates tested for ceftriaxone 232 2020 up 129.7% 13th Proportion of isolates with decreased susceptibility or resistance (DS 0 2020 — 13th Hospital discharges by diagnosis, day cases, per 100 000 inhabitants 9,962 Per hundred thousand inhabitants 2021 up 23.7% 6th Proportion of isolates with resistance to azithromycin reported to WHO 9.1 2020 down 8.1% 21st Number of isolates tested for azithromycin 232 2020 up 129.7% 14th Households with out-of-pocket payments greater than 40% of capacity to 2.9% 2020 up 95.6% 22nd Proportion of isolates with resistance to ciprofloxacin reported to WH 50.8 2018 down 21.9% 37th Number of isolates tested for ciprofloxacin 189 2018 up 83.5% 21st Proportion of isolates with decreased susceptibility or resistance (DS 4.8 2018 — 8th Number of isolates tested for extended-spectrum cephalosporins 189 2018 up 83.5% 19th Proportion of children at the end of lower secondary achieving at leas 77.8% 2015 up 3.3% 27th Exports of beer (barley) in 1000s hectolitres 688 2009 up 8.7% 6th Proportion of isolates with decreased susceptibility or resistance (DS 4.8 2018 — 5th Number of isolates tested for cefixime 189 2018 up 83.5% 9th Civil registration coverage of cause-of-death 100.0% 2012 unchanged 1st Alcohol-related road traffic crashes with fatalities 23.4% 2010 up 74.6% 10th Alcohol-related road traffic crashes with fatalities 23.4% 2010 up 74.6% 10th Sales of wine in 1000s hectolitres 13.1 2007 down 6.7% 47th Alcohol-related road traffic crashes with fatalities, per 100,000 pop 0.7 2010 down 46.2% 19th ← Previous Page 18 of 19 Next →